Skip Navigation



JAC Advance Access published online on December 19, 2003

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh032
© 2003 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/2/329    most recent
dkh032v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bertazzoni Minelli, E.
Right arrow Articles by Bartolozzi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertazzoni Minelli, E.
Right arrow Articles by Bartolozzi, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The British Society for Antimicrobial Chemotherapy

Original article

Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty

E. Bertazzoni Minelli 1 *, A. Benini 1 , B. Magnan 2 , and P. Bartolozzi 2

1 Department of Medicine and Public Health, Unit of Pharmacology, Policlinico G.B. Rossi, 37134 Verona;
2 Department of Biomedical and Surgical Sciences, Orthopaedic Clinic, University of Verona, Verona, Italy

* Corresponding author. E-mail: elisa.bertazzoni{at}univr.it.

Received 4 July 2003 ; revised 10 October 2003 ; accepted 14 October 2003

Abstract

Aim: Evaluation of the delivery of gentamicin and vancomycin from polymethylmethacrylate (PMMA) spacers before and after implantation for the treatment of total hip replacement infections.

Methods: Twenty industrially produced spacers containing gentamicin (1.9%) were utilized. Vancomycin (2.5%) mixed with PMMA cement was used to fill holes drilled in the cement of 14 of the 20 spacers immediately before implantation. The spacers were removed from 20 patients 3-6 months after implantation and then immersed in phosphate buffer at 37°C for 10 days. Antibiotic concentrations were determined by fluorescence polarization immunoassay.

Results: Gentamicin and vancomycin were still present in all the spacers removed from the patients. The release of gentamicin alone and in combination with vancomycin was in the range 0.05%-0.4% of the initial amount present, whereas the release of vancomycin was in the range 0.8%-3.3%. The release kinetics showed a similar pattern for both drugs. After a high initial release of drug, a reduced, but constant, elution was observed over the next few days.

Conclusions: The delivery of gentamicin and vancomycin from PMMA cement was high initially, with sustained release over several months. Incorporation of vancomycin into the surface of the spacers permitted spacers to be prepared with multiple antibiotics present and without adversely affecting the release kinetics of the agents. The gentamicin-vancomycin combination shows potential for the treatment of infection following total hip replacement in specific patients.

Keywords: antibiotic combination, antibiotic-loaded cement, drug delivery system, surgical wound infection, topical administration
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
C. Jacobs, C. P. Christensen, and M. E. Berend
Static and Mobile Antibiotic-impregnated Cement Spacers for the Management of Prosthetic Joint Infection
J. Am. Acad. Ortho. Surg., June 1, 2009; 17(6): 356 - 368.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
J. P. Whittaker, R. E. Warren, R. S. Jones, and P. A. Gregson
Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection?
J Bone Joint Surg Br, January 1, 2009; 91-B(1): 44 - 51.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
R. O. Darouiche, M. D. Mansouri, D. Zakarevicz, A. AlSharif, and G. C. Landon
In Vivo Efficacy of Antimicrobial-Coated Devices
J. Bone Joint Surg. Am., April 1, 2007; 89(4): 792 - 797.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
B. N Patrick, M. P Rivey, and D. R Allington
Acute Renal Failure Associated with Vancomycin- and Tobramycin-Laden Cement in Total Hip Arthroplasty
Ann. Pharmacother., November 1, 2006; 40(11): 2037 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Kelm, T. Regitz, E. Schmitt, W. Jung, and K. Anagnostakos
In Vivo and In Vitro Studies of Antibiotic Release from and Bacterial Growth Inhibition by Antibiotic-Impregnated Polymethylmethacrylate Hip Spacers
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 332 - 335.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
H. P. Stallmann, C. Faber, and P. I. J. M. Wuisman
Response to: Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty
J. Antimicrob. Chemother., August 1, 2004; 54(2): 570 - 570.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.